Gryphon Financial Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.21M | Buy |
5,668
+465
| +9% | +$471K | 0.53% | 32 |
|
|
2025
Q4 | $5.59M | Buy |
5,203
+224
| +4% | +$214K | 0.6% | 25 |
|
|
2025
Q3 | $3.8M | Buy |
4,979
+729
| +17% | +$542K | 0.43% | 33 |
|
|
2025
Q2 | $3.31M | Buy |
4,250
+23
| +0.5% | +$17.9K | 0.43% | 33 |
|
|
2025
Q1 | $3.49M | Buy |
4,227
+409
| +11% | +$340K | 0.5% | 30 |
|
|
2024
Q4 | $2.95M | Sell |
3,818
-528
| -12% | -$437K | 0.42% | 35 |
|
|
2024
Q3 | $3.85M | Buy |
4,346
+339
| +8% | +$305K | 0.52% | 27 |
|
|
2024
Q2 | $3.63M | Buy |
4,007
+294
| +8% | +$235K | 0.54% | 26 |
|
|
2024
Q1 | $2.89M | Buy |
3,713
+1,389
| +60% | +$989K | 0.48% | 28 |
|
|
2023
Q4 | $1.35M | Buy |
2,324
+377
| +19% | +$220K | 0.24% | 63 |
|
|
2023
Q3 | $1.05M | Sell |
1,947
-33
| -2% | -$17K | 0.24% | 53 |
|
|
2023
Q2 | $929K | Sell |
1,980
-6
| -0.3% | -$2.52K | 0.2% | 62 |
|
|
2023
Q1 | $682K | Buy |
1,986
+453
| +30% | +$153K | 0.16% | 75 |
|
|
2022
Q4 | $561K | Buy |
1,533
+43
| +3% | +$15.2K | 0.13% | 91 |
|
|
2022
Q3 | $482K | Buy |
1,490
+89
| +6% | +$28.2K | 0.12% | 99 |
|
|
2022
Q2 | $454K | Buy |
1,401
+223
| +19% | +$66.9K | 0.11% | 104 |
|
|
2022
Q1 | $337K | Buy |
1,178
+94
| +9% | +$24.2K | 0.07% | 146 |
|
|
2021
Q4 | $300K | Buy |
1,084
+43
| +4% | +$10.9K | 0.06% | 167 |
|
|
2021
Q3 | $241K | Buy |
1,041
+50
| +5% | +$12.3K | 0.05% | 172 |
|
|
2021
Q2 | $194K | Buy |
+991
| New | +$199K | 0.04% | 165 |
|
|
2018
Q3 | – | Sell |
-1,168
| Closed | -$99K | – | 549 |
|
|
2018
Q2 | $99K | Buy |
1,168
+14
| +1% | +$1.15K | 0.04% | 132 |
|
|
2018
Q1 | $90K | Sell |
1,154
-120
| -9% | -$9.66K | 0.05% | 150 |
|
|
2017
Q4 | $107K | Buy |
+1,274
| New | +$108K | 0.06% | 134 |
|
Other funds holding LLY
VCM
VPM
